Well Health Technologies Stock Filter Stocks by Fundamentals
WELL Stock | CAD 5.30 0.10 1.92% |
WELL Health Technologies fundamentals help investors to digest information that contributes to WELL Health's financial success or failures. It also enables traders to predict the movement of WELL Stock. The fundamental analysis module provides a way to measure WELL Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to WELL Health stock.
WELL | Shares Owned by Insiders |
WELL Health Current Valuation Drivers
We derive many important indicators used in calculating different scores of WELL Health from analyzing WELL Health's financial statements. These drivers represent accounts that assess WELL Health's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of WELL Health's important valuation drivers and their relationship over time.
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Market Cap | 151.2M | 1.1B | 937.3M | 626.8M | 910.7M | 956.2M | |
Enterprise Value | 154.7M | 1.0B | 1.3B | 936.3M | 1.3B | 1.4B |
WELL Fundamentals
Return On Equity | 0.11 | ||||
Return On Asset | 0.0245 | ||||
Profit Margin | 0.08 % | ||||
Operating Margin | 0.07 % | ||||
Current Valuation | 1.62 B | ||||
Shares Outstanding | 248.93 M | ||||
Shares Owned By Insiders | 21.32 % | ||||
Shares Owned By Institutions | 6.00 % | ||||
Number Of Shares Shorted | 1.29 M | ||||
Price To Book | 1.52 X | ||||
Price To Sales | 1.35 X | ||||
Revenue | 776.05 M | ||||
Gross Profit | 303.29 M | ||||
EBITDA | 101.88 M | ||||
Net Income | 82 K | ||||
Cash And Equivalents | 48.91 M | ||||
Cash Per Share | 0.25 X | ||||
Total Debt | 426.28 M | ||||
Debt To Equity | 0.48 % | ||||
Current Ratio | 1.14 X | ||||
Book Value Per Share | 3.40 X | ||||
Cash Flow From Operations | 62.59 M | ||||
Short Ratio | 1.25 X | ||||
Earnings Per Share | 0.31 X | ||||
Price To Earnings To Growth | (1.32) X | ||||
Target Price | 7.68 | ||||
Beta | 1.18 | ||||
Market Capitalization | 1.29 B | ||||
Total Asset | 1.41 B | ||||
Retained Earnings | (63.58 M) | ||||
Working Capital | 23.44 M | ||||
Net Asset | 1.41 B |
About WELL Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze WELL Health Technologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of WELL Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of WELL Health Technologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Other Information on Investing in WELL Stock
WELL Health financial ratios help investors to determine whether WELL Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in WELL with respect to the benefits of owning WELL Health security.